报价延迟最少15分钟:2026/03/03 21:32 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
69 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
3.79/4.77
|
|
企业价值
4.28B
|
| 资产负债 |
|
每股账面净值
38.66
|
| 现金流量 |
|
现金流量率
0.08
|
| 损益表 |
|
收益
1.14B
|
|
每股收益
23.82
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
